No headlines found.
No press releases found.
No news found.
S&P 500 Buy-Write Income's (BXMX) investment objective is to provide a high level of current income and gains. The Fund invests its managed assets in a diversified equity portfolio that seeks to substantially replicate price movements of the S&P 500® Index. The Fund also uses an index option strategy of writing (selling) index call options in seeking to moderate the volatility of returns relative to an all equity portfolio.
Nuveen S&P 500 Buy-Write Income Common Shares Of Beneficial Interest trades on the NYSE stock market under the symbol BXMX.
As of April 19, 2024, BXMX stock price declined to $12.47 with 137,938 million shares trading.
BXMX has a beta of 0.74, meaning it tends to be less sensitive to market movements. BXMX has a correlation of 0.66 to the broad based SPY ETF.
BXMX has a market cap of $1.30 billion. This is considered a Small Cap stock.
In the last 3 years, BXMX stock traded as high as $15.22 and as low as $11.72.
BXMX has underperformed the market in the last year with a price return of +1.9% while the SPY ETF gained +21.2%. BXMX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -0.8% and -4.4%, respectively, while the SPY returned +4.3% and -3.5%, respectively.
BXMX support price is $12.45 and resistance is $12.65 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BXMX stock will trade within this expected range on the day.